[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CL2004001293A1 - Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u - Google Patents

Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u

Info

Publication number
CL2004001293A1
CL2004001293A1 CL200401293A CL2004001293A CL2004001293A1 CL 2004001293 A1 CL2004001293 A1 CL 2004001293A1 CL 200401293 A CL200401293 A CL 200401293A CL 2004001293 A CL2004001293 A CL 2004001293A CL 2004001293 A1 CL2004001293 A1 CL 2004001293A1
Authority
CL
Chile
Prior art keywords
dimethyletamide
tiamphenicol
triacetine
florfenicol
chloramphenicol
Prior art date
Application number
CL200401293A
Other languages
English (en)
Inventor
Keith A Simmons Rober Freehauf
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of CL2004001293A1 publication Critical patent/CL2004001293A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CL200401293A 2003-05-29 2004-05-27 Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u CL2004001293A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47429403P 2003-05-29 2003-05-29

Publications (1)

Publication Number Publication Date
CL2004001293A1 true CL2004001293A1 (es) 2005-05-06

Family

ID=33551488

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200401293A CL2004001293A1 (es) 2003-05-29 2004-05-27 Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u

Country Status (24)

Country Link
US (2) US8034845B2 (es)
EP (1) EP1626739B1 (es)
JP (2) JP4728244B2 (es)
KR (1) KR101132079B1 (es)
CN (2) CN1795013A (es)
AR (2) AR044437A1 (es)
AU (2) AU2004247053B2 (es)
BR (1) BRPI0410795B1 (es)
CA (1) CA2526202C (es)
CL (1) CL2004001293A1 (es)
EC (1) ECSP056189A (es)
ES (1) ES2492537T3 (es)
IL (1) IL172224A0 (es)
MX (1) MXPA05012827A (es)
MY (1) MY146351A (es)
NO (1) NO20056223L (es)
NZ (1) NZ543594A (es)
PE (1) PE20050386A1 (es)
PL (2) PL1626739T3 (es)
RU (1) RU2359659C2 (es)
TW (1) TW200505425A (es)
UA (1) UA81676C2 (es)
WO (1) WO2004110494A1 (es)
ZA (1) ZA200509544B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11337894B2 (en) 2018-06-15 2022-05-24 James T. Doubet Syringe adapter for animal medication
US10709850B2 (en) 2018-06-15 2020-07-14 James T. Doubet Syringe adapter for medication
US11090444B2 (en) 2018-06-15 2021-08-17 James T. Doubet Syringe adapter for medication
US11097058B2 (en) 2018-06-15 2021-08-24 James T. Doubet Syringe adapter for medication
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
AR044437A1 (es) 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
MX2007007528A (es) * 2004-12-21 2007-10-08 Intervet Int Bv Composicion veterinaria inyectable.
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
KR101544584B1 (ko) * 2006-11-01 2015-08-13 프로노바 바이오파마 너지 에이에스 오메가-3 지질 화합물
MX2009004336A (es) * 2006-11-01 2009-05-22 Pronova Biopharma Norge As Lipidos omega-3 alfa-sustituidos que son activadores o moduladores del receptor activado por proliferadores de peroxisoma (ppar).
US8044230B2 (en) * 2006-12-13 2011-10-25 Intervet Inc. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
CA2672863A1 (en) * 2006-12-19 2008-07-17 Schering-Plough Ltd. Effervescent formulations of florfenicol for addition in drinking water systems
PE20091171A1 (es) * 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol
FR2925334A1 (fr) * 2007-12-21 2009-06-26 Ceva Sante Animale Sa Nouvelles compositions antibacteriennes
EP2321269B1 (en) * 2008-07-30 2018-09-19 Intervet International B.V. Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol
WO2011046853A1 (en) 2009-10-12 2011-04-21 Boehringer Ingelheim Vetmedica Gmbh Containers for compositions comprising meloxicam
KR101140167B1 (ko) * 2009-11-04 2012-04-24 최기동 동물용 의약 조성물 및 이를 포함하는 동물용 의약품
BRPI1002021A2 (pt) 2010-01-21 2012-05-22 Nanocore Biotecnologia S A composições farmacêuticas para tratamento de infecções bacterianas
BRPI1002023A2 (pt) 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
RU2606855C2 (ru) * 2010-12-22 2017-01-10 Байер Интеллектчуал Проперти Гмбх Повышение иммунного отклика у видов крупного рогатого скота
EP2925353B1 (en) * 2012-11-29 2019-03-13 Cornell University Vaccine for intrauterine disease
EA028381B1 (ru) * 2014-08-08 2017-11-30 Александр Петрович Мерабишвили Фармацевтический препарат ветеринарного назначения
EA028412B9 (ru) * 2014-08-08 2018-03-30 Александр Петрович Мерабишвили Фармацевтический препарат ветеринарного назначения
RU2563826C1 (ru) * 2014-08-21 2015-09-20 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Инъекционная антибактериальная фармацевтическая композиция
EP3313376A2 (en) * 2015-06-26 2018-05-02 Bayer Animal Health GmbH Methods of modulating cytosolic dna surveillance molecules
US20180187263A1 (en) * 2017-01-05 2018-07-05 Iowa State University Research Foundation, Inc. Kits for diagnostic detection and prevention of feedlot bovine respiratory disease
USD890925S1 (en) 2018-06-15 2020-07-21 James T. Doubet Syringe adapter for medication
US20190388625A1 (en) 2018-06-15 2019-12-26 James T. Doubet Syringe adapter for medication
WO2020002234A1 (en) * 2018-06-25 2020-01-02 Intervet International B.V. Compounds useful for the treatment of infection with mannheimia haemolytica or histophilus somni

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2671748A (en) * 1950-05-18 1954-03-09 Parke Davis & Co Composition of matter
ES8104203A1 (es) * 1979-02-05 1981-04-16 Schering Corp Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
US5105009A (en) 1983-06-02 1992-04-14 Zambon S.P.A. Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
NZ234802A (en) * 1989-08-14 1992-11-25 Merck & Co Inc Long acting injectable formulations comprising an avermectin compound and triacetin. treatment for internal and external parasites of animals
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
US5663361A (en) 1996-08-19 1997-09-02 Schering Corporation Process for preparing intermediates to florfenicol
AU739469B2 (en) * 1996-12-20 2001-10-11 Alza Corporation Gel composition and methods
CA2285052C (en) 1997-05-06 2004-06-29 Norbrook Laboratories Limited Improvements in or relating to long-acting antimicrobials
CA2211949A1 (en) * 1997-07-21 1999-01-29 David Farley Johnson Nonaqueous compositions for parenteral administration
JP2003512290A (ja) 1997-09-10 2003-04-02 メルク エンド カムパニー インコーポレーテッド 家畜抗菌剤としての８ａ−アザライド
NZ504783A (en) * 1997-12-03 2002-12-20 Merck & Co Inc Long acting injectable formulations containing hydrogenated castor oil
ES2359973T3 (es) * 1998-03-19 2011-05-30 MERCK SHARP &amp; DOHME CORP. Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
US6136838A (en) 1998-03-19 2000-10-24 Merck & Co., Inc. Sulfurpentafluorophenylpyrazoles for controlling ectoparasitic infestations
US6174540B1 (en) * 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
JP2001226257A (ja) * 2000-02-17 2001-08-21 Material Eng Tech Lab Inc 溶液製剤
US6787568B1 (en) 2000-11-27 2004-09-07 Phoenix Scientific, Inc. Antibiotic/analgesic formulation and a method of making this formulation
CA2428993C (en) * 2000-11-29 2011-05-31 Lyotropic Therapeutics, Inc. Solvent systems for pharmaceutical agents
IL163749A0 (en) 2002-03-08 2005-12-18 Schering Plough Ltd Novel florfenicol-type antibiotics
US6790867B2 (en) * 2002-05-20 2004-09-14 Schering-Plough Animal Health Corporation Compositions and method for treating infection in cattle and swine
CN1507858A (zh) 2002-12-19 2004-06-30 王玉万 含氟化氯霉素的兽用液体制剂
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
AR044437A1 (es) 2003-05-29 2005-09-14 Schering Plough Ltd Composiciones y metodo para el tratamiento de infecciones en ganado vacuno y porcino
EP1626980A4 (en) * 2003-05-29 2007-07-04 Univ Washington NEUROACTIVE 13,24-CYCLO-18,21-DINORCHOLANES AND STRUCTURELY RELATED PENTACYCLIC STEROIDS
CN100579532C (zh) 2003-12-23 2010-01-13 先灵-普劳有限公司 具有改善水溶性的氟苯尼考前药
WO2005066119A2 (en) 2003-12-31 2005-07-21 Schering-Plough Ltd. Antibacterial 1-(4-mono-and di-halomethylsulphonylphenyl)-2-acylamino-3-fluoropropanols and preparation thereof
MX2007007528A (es) 2004-12-21 2007-10-08 Intervet Int Bv Composicion veterinaria inyectable.
CA2621961A1 (en) 2005-09-07 2007-03-15 Schering-Plough Ltd. A process for preparing oxazolidine protected aminodiol compounds useful as intermediates to florfenicol
US8119667B2 (en) 2005-12-29 2012-02-21 Schering-Plough Animal Health Corporation Carbonates of fenicol antibiotics
US8044230B2 (en) 2006-12-13 2011-10-25 Intervet Inc. Water-soluble prodrugs of chloramphenicol, thiamphenicol, and analogs thereof
US20080153906A1 (en) 2006-12-13 2008-06-26 Celly Chander S Water-Soluble Phenicol Prodrugs in a Lipophilic Vehicle System
US8084643B2 (en) 2006-12-13 2011-12-27 Intervet Inc. Water-soluble prodrugs of florfenicol and its analogs
CA2672863A1 (en) 2006-12-19 2008-07-17 Schering-Plough Ltd. Effervescent formulations of florfenicol for addition in drinking water systems
CA2685264A1 (en) 2007-04-27 2008-11-06 Schering-Plough Ltd. Compounds and methods for enhancing solubility of florfenicol and structurally-related antibiotics using cyclodextrins
KR20100022999A (ko) 2007-05-30 2010-03-03 쉐링-프라우 리미티드 플로르페니콜에 대한 중간체로서 유용한 옥사졸린-보호된 아미노디올 화합물의 제조방법
CA2693922A1 (en) 2007-07-25 2009-01-29 Intervet International B.V. Process for preparing oxazolidine-and oxazolidinone-aminodiols
AU2008324852A1 (en) 2007-11-09 2009-05-14 Intervet International B.V. Fast release solid formulation, preparation and use thereof
PE20091171A1 (es) 2007-12-14 2009-08-03 Schering Plough Ltd Proceso para recuperar florfenicol y analogos de florfenicol

Also Published As

Publication number Publication date
JP4728244B2 (ja) 2011-07-20
IL172224A0 (en) 2009-02-11
TW200505425A (en) 2005-02-16
PL1626739T3 (pl) 2014-10-31
CA2526202C (en) 2012-07-03
RU2005141127A (ru) 2006-06-10
KR20060016093A (ko) 2006-02-21
JP2007269801A (ja) 2007-10-18
EP1626739B1 (en) 2014-05-21
AR101380A2 (es) 2016-12-14
AR044437A1 (es) 2005-09-14
MY146351A (en) 2012-08-15
US20040242546A1 (en) 2004-12-02
ECSP056189A (es) 2006-08-30
PE20050386A1 (es) 2005-06-23
CN102342925A (zh) 2012-02-08
RU2359659C2 (ru) 2009-06-27
UA81676C2 (ru) 2008-01-25
EP1626739A1 (en) 2006-02-22
US20120077764A1 (en) 2012-03-29
BRPI0410795B1 (pt) 2017-12-19
AU2004247053B2 (en) 2010-11-11
NO20056223L (no) 2005-12-29
ES2492537T3 (es) 2014-09-09
ZA200509544B (en) 2007-01-31
PL380481A1 (pl) 2007-02-05
US9084719B2 (en) 2015-07-21
BRPI0410795A (pt) 2006-06-20
US8034845B2 (en) 2011-10-11
KR101132079B1 (ko) 2012-04-20
CA2526202A1 (en) 2004-12-23
AU2004247053A1 (en) 2004-12-23
NZ543594A (en) 2010-03-26
AU2010235885A1 (en) 2010-11-11
MXPA05012827A (es) 2006-02-13
CN1795013A (zh) 2006-06-28
WO2004110494A1 (en) 2004-12-23
JP2006528705A (ja) 2006-12-21

Similar Documents

Publication Publication Date Title
CL2004001293A1 (es) Composicion farmaceutica que comprende compuestos antibacterianos como florfenicol, tiamfenicol, cloramfenicol en combinacion con al menos un portador seleccionado de triacetina, dimetilacetamida o una mezcla de ellas; y su uso en el tratamiento de u
CY2023026I1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
BR0300500B1 (pt) composiÇço poliolefÍnica, processo para estabilizaÇço de uma poliolefina e uso de uma mistura.
ES2422556T3 (es) Tratamiento de hepatitis vírica
BRPI0614205A2 (pt) composto, composição farmacêutica, e, uso de composto
BRPI0814593A2 (pt) Composto, composição farmacêutica que o contém e uso do composto.
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
CL2007003244A1 (es) Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
CR7820A (es) Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos
ATE533481T1 (de) Formulierung mit metformin und vildagliptin
ECSP056229A (es) Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres
BRPI0312649A2 (pt) compostos, composições farmacêuticas contendo os mesmos, e processos de uso para os mesmos.
DE602004000926D1 (de) Antimikrobielle Glaszusammensetzung und diese enthaltende antimikrobielle Polymerzusammensetzung
CL2003002731A1 (es) Compuesto derivado de quinazolina de formula definida, que actua como inhibidor de la kinasa aurora; procedimiento de preparacion del compuesto; composicion farmaceutica que comprende al compuesto y uso del compuesto; util para el tratamiento de enfe
CL2007003722A1 (es) Compuestos derivados de propionamida n-sustituida por heterociclo, activadores de glucoquinasa; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento o prevencion de la diabetes.
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
BRPI0717369A2 (pt) Composto, medicamento, composição farmacêutica que o contém e uso do composto.
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
BRPI0619911A2 (pt) composto, pró-droga, agente farmacêutico, e, uso do composto
CL2007003693A1 (es) Compuestos derivados de pirido [3,2-b] [1,4] tiazina; composicion farmaceutica que contiene dichos compuestos; y su uso en el tratamiento de infecciones bacterianas.
CL2007003044A1 (es) Compuestos derivados de benzoxazina; composicion farmaceutica que los comprende; y uso para el tratamiento de un trastorno psicotico, bipolar, depresivo y abuso o dependencia de sustancias entre otros.
CL2007003847A1 (es) Compuestos derivados de pirimidinas 2,4,5 tri-sustituidas; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento del cancer.
DE602006018391D1 (de) Photoresistmonomer, dessen Polymer und diesen enthaltende Fotolackzusammensetzung
DE60318590D1 (de) Vernetzbare acrylkautschukzusammensetzung und formkörper
DE60306379D1 (de) Diffusionskontrolliertes wirkstoffabgabesystem mit fluorosiloxan-matrix